Advanced Ovarian Cancer and Topotecan
Links shared publicly online about this topic
Topotecan Tanks in Advanced Ovarian Cancer - QualityPoint Technologies
qualitypointtech.net — “The latest attempt to improve on platinum/taxane by adding topotecan was unsuccessful, as were 4 previous trials. Medscape Medical News” View full resource at qualitypointtech.net
Most Recently Shared on October 13, 2010 at 8:37 pm By:
Topotecan Tanks in Advanced Ovarian Cancer: The latest attempt to improve on platinum/taxane by adding topotecan w... http://bit.ly/a2x1PW
Another Confirmation of the Inactivity of Topotecan in Ovarian Cancer " J. Natl. Cancer Inst.
jnci.oxfordjournals.org — “Another Confirmation of the Inactivity of Topotecan in Ovarian Cancer " J. Natl. Cancer Inst.” View full resource at jnci.oxfordjournals.org
Most Recently Shared on October 26, 2010 at 2:08 pm By:
Editorial on inactivity of topotecan: "Does the addition of topotecan to a platinum and taxane backbone improve... http://fb.me/IsmiXE4Q
Adding Topotecan to Standard Treatment for Ovarian Cancer Does Not Improve Progression-Free Survival " J. Natl. Cancer Inst.
jnci.oxfordjournals.org — “Adding Topotecan to Standard Treatment for Ovarian Cancer Does Not Improve Progression-Free Survival " J. Natl. Cancer Inst.” View full resource at jnci.oxfordjournals.org
Most Recently Shared on October 26, 2010 at 2:04 pm By:
Topotecan does not improve overall survival in ovarian cancer. Press release and study. http://fb.me/CtSqCUOS
Oncology Article | Topotecan Ovarian Neoplasms
mdlinx.com — “Topotecan weekly versus conventional 5-day schedule in patients with platinum-resistant ovarian cancer: A randomized multicenter phase II trial of the North-Eastern German Society of Gynecological Oncology Ovarian Cancer Study Group” View full resource at mdlinx.com
Most Recently Shared on December 7, 2010 at 6:40 am By:
Topotecan weekly versus conventional 5-day schedule in patients with platinum-resistant ovarian cancer... http://bit.ly/fVA9K7 #oncology
Ovarian Cancer: Adding Topotecan To Standard Treatment Does Not Improve Progression-Free Survival
medicalnewstoday.com — “Adding topotecan to carboplatin plus paclitaxel, the standard treatment for ovarian cancer, does not improve progression-free survival in patients and leads to greater toxicity, according to a stu” View full resource at medicalnewstoday.com
Most Recently Shared on October 12, 2010 at 1:37 pm By:
Ovarian Cancer: Adding Topotecan To Standard Treatment Does Not Improve Progression-Free Survival Adding topotecan to c.. http://dld.bz/znNq
Study finds inactivity of topotecan regimen to treat ovarian cancer
news-medical.net — “Adding topotecan to carboplatin plus paclitaxel, the standard treatment for ovarian cancer, does not improve progression-free survival in patients and leads to greater toxicity, according to a study published online October 11 in the Journal of the National Cancer Institute.” View full resource at news-medical.net
Most Recently Shared on October 12, 2010 at 10:05 am By:
Study finds inactivity of topotecan regimen to treat ovarian cancer: Adding topotecan to carboplatin plus paclitax... http://bit.ly/djUgaz
Study finds inactivity of topotecan regimen to treat ovarian cancer
news-medical.net — “Adding topotecan to carboplatin plus paclitaxel, the standard treatment for ovarian cancer, does not improve progression-free survival in patients and leads to greater toxicity, according to a study published online October 11 in the Journal of the National Cancer Institute.” View full resource at news-medical.net
Most Recently Shared on October 12, 2010 at 6:35 am By:
Study finds inactivity of topotecan regimen to treat ovarian cancer: Adding topotecan to carboplatin plus paclitax... http://bit.ly/9WfAV6
Treatment for Advanced Ovarian Cancer Effective
disabled-world.com — “New treatment regimen shown effective against advanced ovarian cancer” View full resource at disabled-world.com
Most Recently Shared on June 6, 2010 at 11:31 pm By:
Treatment for Advanced Ovarian Cancer Effective http://ff.im/-lA8Uw
Adding topotecan to standard treatment for ovarian cancer does not improve progression-free survival
physorg.com — “Adding topotecan to carboplatin plus paclitaxel, the standard treatment for ovarian cancer, does not improve progression-free survival in patients and leads to greater toxicity, according to a study published online October 11 in the Journal of the National Cancer Institute.” View full resource at physorg.com
Most Recently Shared on October 11, 2010 at 11:51 pm By:
Adding topotecan to standard treatment for ovarian cancer does not improve progression-free survival http://bit.ly/cMGVsi
Ovarian Cancer
springer.com — “Ovarian carcinoma continues to be responsible for more deaths than all other gynecologic malignancies combined, due to a continued inability to achieve detection of early (rather than advanced) stage disease and the lack of ...” View full resource at springer.com
Most Recently Shared on March 16, 2012 at 6:27 pm By:
Ovarian Cancer: Second Editionseries:Cancer Treatment and ResearchOvarian carcinoma continues to be responsible ... http://t.co/GanmC9SK
Ovarian cancer advances when genes are silenced
eurekalert.org — “Researchers at the Duke Cancer Institute have found evidence of epigenetics at work on a genome-wide scale in cases of ovarian cancer. One major biological signaling pathway in particular was found to contain many genes influenced by DNA methylation -- a mechanism for turning off genes -- in tumor cells.” View full resource at eurekalert.org
Most Recently Shared on December 14, 2010 at 4:41 pm By:
Ovarian cancer advances when genes are silenced ---> http://dld.bz/ANpD
Ovarian cancer advances when genes are silenced
labspaces.net — “There are many mechanisms that alter the activity of genes -- direct changes to the DNA code like mutations and deletions, or changes that control when genes are switched on and off, called epigenetic means. Tumor-suppressor genes are often inactivated through epigenetics, which provides an opening for the cancerous growth of cells.” View full resource at labspaces.net
Most Recently Shared on December 14, 2010 at 4:48 pm By:
Ovarian cancer advances when genes are silenced - http://is.gd/iJVou
Key advances in ovarian cancer (ASCO 2010 ) Video
vodpod.com — “Prof Jonathan Ledermann outlines some of the key advances in ovarian cancer that have been presented at ASCO 2010. Prof Ledermann discusses research demonstrating the effectiveness of combining bevacizumab with chemotherapy as first line treatment of ovarian cancer. A second key presentation was research indicating that PARP inhibitors are effective at treating not just ovarian cancer caused by BRCA mutation but also high grade serous cancer. If this result is confirmed in further studies, it wo” View full resource at vodpod.com
Most Recently Shared on July 22, 2010 at 9:59 pm By:
Prof Jonathan Ledermann outlines some of the key advances in ovarian cancer that have been presented at ASCO 2010. Pro… http://bit.ly/b7acun
Ovarian cancer advances when genes are silenced
sciencedaily.com — “Researchers have found evidence of epigenetics at work on a genome-wide scale in cases of ovarian cancer. One major biological signaling pathway in particular was found to contain many genes influenced by DNA methylation -- a mechanism for turning off genes -- in tumor cells.” View full resource at sciencedaily.com
Most Recently Shared on December 14, 2010 at 3:38 am By:
Ovarian cancer advances when genes are silenced: Researchers have found evidence of epigenetics at work on a gen... http://bit.ly/hM8eZ9
7 Clues to Ovarian Cancer
webmd.com — “Seven symptoms often reported to doctors are associated with ovarian cancer, according to a new study from the U.K., dispelling the idea that the deadly cancer is a ''silent killer'' with few clues until the advanced stages.” View full resource at webmd.com
Most Recently Shared on August 25, 2009 at 11:47 pm By:
7 Clues to Ovarian Cancer: Seven symptoms often reported to doctors are associated with ovarian cancer, accordin.. http://bit.ly/17OJmo
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
MedicalFeed
Medical news and updates about medical articles and discussion in Google knols and in many medical websites.
-
J Nat'l Cancer Inst
JNCI, an Oxford University Press journal, publishes peer-reviewed original research and is an internationally acclaimed source for cancer news and information.
-
J Nat'l Cancer Inst
JNCI, an Oxford University Press journal, publishes peer-reviewed original research and is an internationally acclaimed source for cancer news and information.
Advertisement

